Sign Up Today and Learn More About Kiffik Biomedical Stock
Invest in or calculate the value of your shares in Kiffik Biomedical or other pre-IPO companies through EquityZen's platform.
Kiffik Biomedical Stock
Kiffik Biomedical developed a novel technology that transmits health data.
About Kiffik Biomedical Stock
Founded
2018
Headquarters
Providence, RI, US
Industries
Software, Artificial Intelligence, Data and Analytics
Kiffik Biomedical Press Mentions
Stay in the know about the latest news on Kiffik Biomedical
KIFFIK Biomedical Closes Oversubscribed Series A to Advance Real-Time Molecular Diagnostics Platform
morningstar • Dec 17, 2025
KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations
pharmiweb • Aug 13, 2025
Collection device and method of collecting interstitial fluid
patents • Apr 02, 2025
Kiffik Biomedical and Rubix LS Partner to Revolutionize Cancer Diagnostics With Interstitial Fluid and Aptamer Technologies
morningstar • Mar 20, 2025
KIFFIK Biomedical Secures Strategic $50 Million Capital Commitment from GEM
finance • Mar 02, 2024
Kiffik Biomedical Management
Leadership team at Kiffik Biomedical
President and Chief Executive Officer
George Cagna
Chief Investment Officer
Rene Veloso
Join now and verify your accreditation status to gain access to:
- Kiffik Biomedical Current Valuation
- Kiffik Biomedical Stock Price
- Kiffik Biomedical Management
- Available deals in Kiffik Biomedical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Kiffik Biomedical Cap Table and Funding History by Share Class and Liquidity Preferences
- Kiffik Biomedical Revenue and Financials
- Kiffik Biomedical Highlights
- Kiffik Biomedical Business Model
- Kiffik Biomedical Risk Factors
- Kiffik Biomedical Research Report from SACRA Research
Trading Kiffik Biomedical Stock
How to invest in Kiffik Biomedical stock?
Accredited investors can buy pre-IPO stock in companies like Kiffik Biomedical through EquityZen funds. These investments are made available by existing Kiffik Biomedical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Kiffik Biomedical stock?
Shareholders can sell their Kiffik Biomedical stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."